Organic & Biomolecular Chemistry
Paper
CH2Py), 5.11 (t, 1H, ex, J = 4.9 Hz, 5′-OH), 5.03–5.06 (d, 1H, J = H3Py, H6Py, H8Py), 8.17–8.20 (d, 2H, J = 8.9 Hz, H4Py, H10Py),
12.7 Hz, CH2Py), 4.23–4.26 (m, 1H, H3′), 4.12–4.15 (m, 1H, 8.11–8.13 (d, 2H, J = 8.9 Hz, H5Py, H9Py), 8.07 (t, 1H, J = 7.5 Hz,
H2′), 3.98–4.00 (m, 1H, H4′), 3.65–3.69 (m, 1H, H5′), 3.57–3.62 H7Py), 7.67 (d, 1H, J = 8.0 Hz, H6), 7.31–7.33 (m, 2H, DMTr),
(m, 1H, H5′); 13C NMR (DMSO-d6): δ 163.0, 150.6, 140.2 (C6), 7.22–7.26 (m, 2H, DMTr), 7.15–7.20 (m, 5H, DMTr), 6.78–6.84
136.3, 130.54, 130.50, 127.5 (C4Py, C10Py), 127.2 (C5Py, C9Py), (m, 4H, DMTr), 6.07–6.08 (d, 1H, J = 3.9 Hz, H1′), 5.45 (d, 1H,
126.1 (C7Py), 125.1 (C6Py, C8Py), 123.7 (C1Py, C3Py), 123.2, 101.8 ex, J = 6.7 Hz, 3′-OH), 5.13–5.23 (m, 3H, H5, CH2Py), 4.31–4.35
(C5), 86.4 (C1′), 85.2 (C4′), 80.8 (C2′), 71.3 (CH2Py), 68.4 (C3′), (m, 1H, H3′), 4.18–4.20 (m, 1H, H2′), 4.09–4.12 (m, 1H, H4′),
60.5 (C5′).
3.68 (s, 3H, CH3O), 3.65 (s, 3H, CH3O), 3.30–3.34 (m, 1H, H5′;
overlap with H2O), 3.23–3.26 (m, 1H, H5′); 13C NMR
(DMSO-d6): δ 162.9, 158.1, 158.0, 150.4, 144.4, 140.1 (C6),
2′-O-(Pyren-4-yl)methyl-uridine (2Z)
O2,O2′-Anhydrouridine 1 (0.50 g, 2.21 mmol), 4-pyrenemetha- 136.2, 135.3, 135.0, 130.6, 130.5, 129.7 (DMTr), 129.6 (DMTr),
nol (1.03 g, 4.42 mmol), NaHCO3 (37.1 mg. 0.44 mmol), BH3 127.8 (DMTr), 127.6 (DMTr), 127.5 (Py), 127.2 (Py), 126.7 (Py),
in THF (1.10 mL, 1.10 mmol) and anhydrous DMSO (5 mL) 126.1 (Py), 125.1 (Py), 123.68, 123.66 (Py), 123.2, 113.2 (DMTr),
were mixed, reacted, worked up, and purified as described 113.1 (DMTr), 101.5 (C5), 87.2 (C1′), 85.9, 82.9 (C4′), 80.6 (C2′),
above to afford nucleoside 2Y (200 mg, 20%) as a white solid. 71.3 (CH2Py), 68.7 (C3′), 62.7 (C5′), 54.94 (CH3O), 54.92
Rf: 0.4 (10% MeOH in CH2Cl2, v/v); MALDI-HRMS m/z (CH3O). A minor impurity of chloroform at 79.1 ppm was
1
481.1399 ([M + Na]+, C26H22N2O6·Na+, Calc. 481.1370; H NMR identified in the 13C NMR.
(DMSO-d6): δ 11.28 (s, 1H, ex, NH), 8.42 (d, 1H, J = 7.8 Hz, Py),
8.29–8.31 (m, 2H, Py), 8.24–8.26 (d, 1H, J = 7.3 Hz, Py),
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(pyren-4-yl)methyl-uridine (3Z)
8.18–8.22 (m, 3H, Py), 8.07 (t, 1H, J = 7.5 Hz, Py), 8.03 (dd, 1H, Nucleoside 2Z (150 mg, 0.33 mmol), DMTrCl (191 mg,
J = 7.8 Hz, 7.5 Hz, Py), 7.77 (d, 1H, J = 8.0 Hz, H6), 6.08 (d, 1H, 0.49 mmol) and DMAP (∼4 mg) in anhydrous pyridine (5 mL)
J = 5.4 Hz, H1′), 5.39–5.43 (m, 3H, 1 ex, 3′-OH, H5 and CH2Py), were mixed, reacted, worked up and purified as described
5.21–5.24 (d, 1H, J = 12.5 Hz, CH2Py), 5.09 (t, 1H, ex, 5′-OH), above to afford 3Z (200 mg, 80%) as a pale yellow foam. Rf:
4.29–4.33 (m, 1H, H3′), 4.20–4.23 (m, 1H, H2′), 3.97–4.00 0.6 (5% MeOH in CH2Cl2, v/v); MALDI-HRMS m/z 783.2695
(m, 1H, H4′), 3.63–3.68 (m, 1H, H5′), 3.57–3.62 (m, 1H, H5′); ([M
+
Na]+, C47H40N2O8·Na+, Calc. 783.2677); 1H NMR
13C NMR (DMSO-d6): δ 162.8, 150.5, 140.0 (C6), 132.8, 130.8, (DMSO-d6):36 δ 11.36 (s, 1H, ex, NH), 8.45 (d, 1H, J = 7.8 Hz,
130.5, 129.9, 129.0, 127.5 (Py), 127.0 (Py), 126.9 (Py), 126.3 (Py), Py), 8.17–8.33 (m, 6H, Py), 8.05 (t, 2H, H2Py, H7Py), 7.60 (d, 1H,
125.9 (Py), 125.3 (Py), 125.2 (Py), 124.1, 123.5, 121.7 (Py), 101.6 J = 8.2 Hz, H6), 7.30–7.32 (m, 2H, DMTr), 7.17–7.25 (m, 7H,
(C5), 86.0 (C1′), 85.4 (C4′), 80.7 (C2′), 70.2 (CH2Py), 68.4 (C3′), DMTr), 6.78–6.84 (m, 4H, DMTr), 6.07 (d, 1H, J = 4.1 Hz, H1′),
60.6 (C5′).
5.49 (d, 1H, J = 6.2 Hz, ex, 3′-OH), 5.44–5.46 (m, 1H, J =
12.7 Hz, CH2Py), 5.30–5.34 (d, 1H, J = 12.7 Hz, CH2Py), 5.08 (d,
1H, J = 8.2 Hz, H5), 4.38–4.42 (m, 1H, H3′), 4.26–4.28 (m, 1H,
H2′), 4.09–4.12 (m, 1H, H4′), 3.71 (s, 3H, CH3O), 3.69 (s, 3H,
General O5′-DMTr-protection protocol for the preparation of
3Y/3Z (description for ∼1 mmol scale)
The appropriate nucleoside 2 (specific quantities given below) CH3O), 3.30–3.34 (m, 1H, H5′ – partial overlap with H2O),
was co-evaporated twice with anhydrous pyridine and redis- 3.22–3.25 (m, 1H, H5′); 13C NMR (DMSO-d6): δ 162.8, 158.1,
solved in anhydrous pyridine. To this was added 4,4′- 158.0, 150.4, 144.4, 140.0 (C6), 135.3, 135.0, 132.7, 130.9,
dimethoxytritylchloride (DMTrCl) and catalytic N,N-dimethyl- 130.5, 129.9, 129.7 (DMTr), 129.6 (DMTr), 129.0, 127.8 (DMTr),
4-aminopyridine (DMAP), and the reaction mixture was stirred 127.6 (DMTr), 127.5 (Py), 127.1 (Py), 126.8 (Py), 126.7 (DMTr),
at rt under an argon atmosphere until TLC indicated complete 126.3 (C2Py), 126.0 (C7Py), 125.29 (Py), 125.25 (Py), 124.1, 123.5,
conversion (∼14 h). The reaction mixture was diluted with 121.7 (Py), 113.2 (DMTr), 113.1 (DMTr), 101.4 (C5), 86.9 (C1′),
CH2Cl2 (40 mL) and the organic phase was sequentially 85.9, 83.2 (C4′), 80.5 (C2′), 70.2 (CH2Py), 68.7 (C3′), 62.8 (C5′),
washed with water (2 × 30 mL) and sat. aq. NaHCO3 (2 × 55.0 (CH3O).
50 mL). The organic phase was evaporated to near dryness and
the resulting crude co-evaporated with abs. EtOH and toluene
(2 : 1, v/v, 3 × 3 mL) and purified by silica gel column chrom-
General O3′-phosphitylation protocol for the preparation of
4Y and 4Z (description for ∼0.25 mmol scale)
atography (0–5%, MeOH in CH2Cl2, v/v) to afford nucleoside 3 The appropriate nucleoside 3 (specific quantities given below)
(yield specified below).
was co-evaporated with anhydrous 1,2-dichloroethane and
redissolved in anhydrous CH2Cl2. To this was added N,N-diiso-
propylethylamine (DIPEA) and 2-cyanoethyl-N,N-diisopropyl-
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(pyren-2-yl)methyl-uridine (3Y)
Nucleoside 2Y (500 mg, 1.09 mmol), DMTrCl (0.64 g, chlorophosphoramidite (PCl-reagent) and the reaction mixture
1.63 mmol) and DMAP (∼9 mg) in anhydrous pyridine (10 mL) was stirred at rt under an argon atmosphere until TLC
were mixed, reacted, worked up and purified as described indicated complete conversion (∼3 h), whereupon abs. EtOH
above to afford 3Y (0.57 g, 68%) as a pale yellow foam. Rf: (0.3 mL) and CH2Cl2 (5 mL) were sequentially added.
0.6 (5% MeOH in CH2Cl2, v/v); MALDI-HRMS m/z 783.2706 The organic phase was washed with sat. aq. NaHCO3 (2 mL),
([M
(DMSO-d6):35 δ 11.43 (s, 1H, ex, NH), 8.27–8.31 (m, 4H, H1Py, by silica gel column chromatography (40–70% EtOAc in
+
Na]+, C47H40N2O8·Na+, Calc. 783.2677); 1H NMR evaporated to near dryness, and the resulting residue purified
This journal is © The Royal Society of Chemistry 2014
Org. Biomol. Chem., 2014, 12, 7758–7773 | 7769